US › Healthcare

Alpha Cognition Inc (ACOG)

US · Healthcare · Biotechnology

$8.19-3.08%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$6.1M

Revenue YoY

+267.6%

Net profit

$-8.8M

EPS

$-0.40

EPS estimate

$-0.39

Net margin

-144.3%

EPS came in at -0.40 against a street estimate of -0.39 — a miss of 2.6%.

Key statistics

Market cap

$191.6M

Forward P/E

26.9

P/B

3.63

Book value

$2.43

EPS (TTM)

$-1.33

52-week high

$10.14

52-week low

$4.50

50-day MA

$8.99

200-day MA

$6.99

Beta

2.23

Analyst view

Analysts rate Alpha Cognition Inc a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $18.00.

Shareholding

Insiders

5.13%

Institutions

56.80%

Largest institutional holders

Fund	Stake
Opaleye Management Inc	13.30%
Solas Capital Management LLC	8.84%
Awm Investment Company Inc	7.68%
Cable Car Capital LLC	6.35%
Ikarian Capital, LLC	3.84%
Sphera Funds Management Ltd.	2.51%
Alyeska Investment Group, L.P.	1.68%
Aristides Capital LLC	1.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alpha Cognition Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.